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Phosphorylation of the nonstructural NS5A protein is highly conserved among hepatitis C virus (HCV) genotypes. However,
the precise site or sites of phosphorylation of NS5A have not been determined, and the functional significance of
phosphorylation remains unknown. Here, we showed by two-dimensional phosphopeptide mapping that a protein kinase or
kinases present in yeast, insect, and mammalian cells phosphorylated a highly purified HCV genotype 1b NS5A from insect
cells on identical serine residues. We identified a major phosphopeptide (corresponding to amino acids 2193–2212 of the
HCV 1b polyprotein) by using negative-ion electrospray ionization–microcapillary high performance liquid chromatography–
mass spectrometry. The elution time of the phosphopeptide determined by negative-ion electrospray ionization–mass
spectrometry corresponded with the elution time of the majority of 32P-label that was incorporated into the phosphopeptide
by an in vitro kinase reaction. Subsequent analysis of the peak fraction by automated positive-ion electrospray ionization–
tandem mass spectrometry revealed that Ser2194 was the major phosphorylated residue on the phosphopeptide Gp-
SPPSLASSSASQLSAPSLK. Substitution for Ser2194 with Ala resulted in the concomitant disappearance of major in vivo
phosphorylated peptides. Ser2194 and surrounding amino acids are highly conserved in all HCV genotypes, suggesting NS5A
phosphorylation at Ser2194 may be an important mechanism for modulating NS5A biological functions. © 2000 Academic Press
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Hepatitis C virus (HCV) is the major cause of non-A,
non-B hepatitis worldwide (Choo et al., 1990). An esti-
mated 4 million Americans and 2% of the world popula-
tion are clinically affected by HCV; more than half of the
cases progress into chronic infection, often developing
into liver cirrhosis and ultimately hepatocellular carci-
noma (Alter, 1997; Okuda, 2000). However, the mecha-
nisms of HCV pathogenesis remain poorly understood
largely due to the lack of an efficient cell culture system
and an adequate animal model for HCV infection and
replication (Lanford et al., 1994; Yanagi et al., 1997;
Kolykhalov et al., 1997; Moradpour et al., 1998). The
primary anti-HCV therapeutic agents interferon-a (IFN-a)
n combination with ribavirin are ineffective in the major-
ty of cases (Fried and Hoofnagle, 1995; Battaglia and
agmeyer, 2000). The HCV positive-sense single-
tranded RNA genome is translated into a single
olyprotein of .3000 amino acid residues that is subse-
uently cleaved by viral and cellular proteases into at
east nine mature viral structural and nonstructural pro-
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501eins (Lohmann et al., 1996; De Francesco, 1999). Struc-
ural proteins include a nucleocapsid core (C) and two
nvelope glycoproteins, E1 and E2. HCV also encodes
wo proteases, a zinc-dependent metalloprotease en-
oded by the NS2-NS3 region and a serine protease
ncoded by the NS3 region. These proteases, together
ith the NS4A protein (which appears to function as a
ofactor of the NS3 protease), are required for cleavage
f specific regions of the polyprotein into mature pep-
ides. Two proteins are derived by further cleavage of the
S5 protein: NS5B, the RNA-dependent RNA polymer-
se, and NS5A, the subject of this study.
NS5A has recently become a focal point in HCV re-
earch. This interest in NS5A was prompted primarily by
eports linking the amino acid sequence of a discrete
egion of NS5A with response to IFN. Enomoto et al.
1995 and 1996) suggested that the NS5A protein might
onfer IFN resistance to the virus because mutations
ithin the IFN sensitivity-determining region (ISDR) of
he NS5A coding region correlate with increased HCV
FN sensitivity. In support of this hypothesis, we found
hat NS5A binds to and inactivates the IFN-induced PKR
rotein kinase (Gale et al., 1997, 1998, and 1999). Be-
ause PKR is an important component of the antiviral
rm of the IFN host defense system, these data suggesthat down-regulation of PKR by NS5A binding may be
ne mechanism of viral evasion of IFN action. Impor-
0042-6822/00 $35.00
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502 KATZE ET AL.tantly, we also found that NS5A containing multiple mu-
tations within the ISDR region was unable to bind or
inhibit kinase activity (Gale et al., 1997, 1998, and 1999),
providing further evidence for a role of NS5A in subvert-
ing the IFN host defense. Consistent with the apoptotic
effector role of PKR, overexpression of NS5A results in
cellular transformation and inhibition of double-stranded
RNA-induced apoptosis (Gale et al., 1998 and 1999).
Furthermore, NS5A expression is able to partially confer
IFN resistance to otherwise IFN-sensitive viruses (Gale
et al., 1998 and 1999; Polyak et al., 1999; Song et al.,
1999). Interestingly, the carboxyl-terminal domain of
NS5A, including the ISDR, has been reported to exert
potent trans-activating activity, suggesting that NS5A
might function as a viral transcriptional activator (Tani-
moto et al., 1997; Kato et al., 1997). Furthermore, muta-
tions in the ISDR apparently also affect the transcrip-
tional activity of NS5A (Fukuma et al., 1998), but a relation
between NS5A transcriptional activity and HCV IFN re-
sistance has not been established. More recently, we
found that NS5A might play a role in viral pathogenesis
by binding to the Grb2 adaptor protein and perturbing the
mitogen-activated protein kinase (MAPK) kinase-signal-
ing cascade (Tan et al., 1999). In addition, NS5A has been
reported to modulate cell cycle regulatory genes (Ghosh
et al., 1999) and directly interact with a number of cellular
proteins, including a human vesicle-associated mem-
brane protein of 33 kDa (hVAP-33) (Tu et al., 1999), a
novel cellular transcription factor SRCAP (Ghosh et al.,
2000), and the karyopherin b3 protein (Chung et al.,
2000).
It is well established that HCV NS5A is a phosphopro-
tein, primarily phosphorylated on Ser residues, both in
vitro and in vivo (Tanji et al., 1995; Reed et al., 1997, 1998).
Moreover, NS5A readily associates with cellular kinases
that are distinct from the IFN-induced PKR, which itself
does not phosphorylate NS5A (Reed et al., 1998; Ide et
al., 1997; Kim et al., 1999). Although the precise molecular
mechanisms are not understood, there is evidence that
NS5A may be subjected to hyperphosphorylation
through the association/action of other HCV nonstruc-
tural proteins, including NS4 (Tanji et al, 1995; Asabe et
al., 1997; Kaneko et al., 1994; Koch and Bartenschlager,
1999; Neddermann et al., 1999) and NS2 (Liu et al., 1999).
Recent reports suggest that hyperphosphorylation may
also depend on an active NS3 protease, implying that
hyperphosphorylation depends on proper cleavage and
NS5A conformation (Koch and Bartenschlager, 1999;
Neddermann et al., 1999). The functional significance of
NS5A phosphorylation has not been addressed, partly
due to the lack of precise information on the phosphor-
ylation sites of the protein. However, the phosphorylation
of NS5A (or NS5) is a conserved trait among divergent
HCV isolates (Reed et al., 1997) and among other mem-
bers of the Flaviviridae (Reed et al., 1998), suggesting it
may play an important role in the flavivirus life cycle.Thus the identification of the phosphorylated sites of
NS5A is likely to be crucial to the elucidation of the
regulation and function of NS5A.
Deletion mapping and site-directed mutagenesis
showed that Ser2197, Ser2201, and Ser2204 may be required
for hyperphosphorylation, whereas sites closer to the
carboxyl terminal may be important for NS5A basal phos-
phorylation (Tanji et al., 1995). However, these studies
were assessed by SDS–PAGE gel-shift analysis, which
does not accurately indicate the sites or levels of protein
phosphorylation. More recently, Reed and Rice (1999)
identified Ser2321 as the major phosphorylation site in the
HCV 1a genotype NS5A by phosphoamino acid analysis
and two-dimensional (2-D) phosphopeptide sequencing,
although this site is not conserved across HCV geno-
types. Here, we sought to determine the precise phos-
phorylation site or sites in NS5A by using a sensitive and
direct approach that combines 2-D phosphopeptide
mapping and electrospray ionization–mass spectrometry
(ESI-MS) (Watts et al., 2000). In contrast to previous
findings, we found that Ser2194 is a major phosphorylation
ite of NS5A in HCV 1b genotype and likely in HCV 1a
enotype as well. Sequence comparison between vari-
us HCV genotypes revealed that this site is highly
onserved in the genotypes examined. Further, Ser2194 is
apparently phosphorylated by a cellular protein kinase or
kinases present in yeast, insect, and mammalian cells,
suggesting that the protein kinase is evolutionarily con-
served.
RESULTS
Because of the diverse functions attributed to the HCV
NS5A protein and the possibility that phosphorylation
may affect its biological properties, we undertook studies
to identify the major phosphorylated residue or residues
of NS5A. Direct determination of NS5A phosphorylation
sites in vivo is not possible due to the lack of an efficient
cell culture system for HCV infection and the low recov-
ery yield of phosphorylated NS5A from typical cell ly-
sates. We thus determined the sites of NS5A phosphor-
ylation by comparing in vitro and in vivo generated 2-D
phosphopeptide maps of NS5A and subsequent analysis
by ESI-MS of the in vitro derived phosphopeptides. This
established experimental approach is summarized in
Fig. 1.
Expression and characterization of recombinant
NS5A
For NS5A substrate, we used baculovirus-ex-
pressed recombinant NS5A protein derived from HCV
genotype 1b. Consecutive chromatographic separa-
tions on DEAE-Sepharose and Mono Q were per-
formed to purify the native NS5A protein essentially to
homogeneity as revealed by the silver-stained SDS–
PAGE analysis (Fig. 2A). The presence of NS5A in this
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503MAJOR HCV NS5A PHOSPHORYLATION SITEband was confirmed by Western blotting with an anti-
body specific to NS5A (data not shown). When this
NS5A preparation was subjected to an in vitro kinase
assay, we observed that the baculovirus-expressed
NS5A protein was efficiently self-phosphorylated (Fig.
2B), suggesting that either the purified NS5A pos-
sesses intrinsic protein kinase activity or a contami-
nant insect protein kinase was copurifying with NS5A.
The latter is consistent with previous reports that
NS5A can tightly associate with a protein kinase or
kinases (Reed et al., 1997; Ide et al., 1997; Kim et al.,
999). Furthermore, this NS5A kinase activity could
eadily be inactivated by heat treatment of the NS5A
reparation (Fig. 2C, lane 1). Consistent with the pre-
ious observation that casein kinase II (CKII) is capa-
le of phosphorylating NS5A in vitro (Kim et al., 1999),
he heat-treated NS5A sample remained an excellent
ubstrate for phosphorylation by exogenous CKII (lane
).
dentification of a major phosphopeptide from NS5A
These above results suggest that the NS5A protein
s likely phosphorylated in the insect cells before pu-
ification, possibly by the associated kinase or ki-
ases. Purified NS5A was subjected to trypsin and
hymotrypsin digestion and the resulting peptide mix-
ure was analyzed by negative-ion microcapillary
PLC (mLC)-ESI-MS/MS using a diagnostic ion scan-
FIG. 1. Schematic representation of the experimental approach, us-
ing both in vivo and in vitro labeled material for the determination of
NS5A phosphorylation sites. Due to the low amounts of phosphorylated
NS5A recovered from in vivo sources, the in vivo derived samples are
correlated at the level of 2-D phosphopeptide mapping, whereas larger
amounts of in vitro generated samples are analyzed by ESI-MS.ing procedure that indicated the presence of phos-
hopeptides in the column effluent as well as their
e
aolecular weights. This was achieved by the cyclic
pplication of three sequential scanning conditions
nder automated instrument control as described un-
er Materials and Methods. Because these three con-
itions were cycled fast in comparison to the elution
ime of the phosphopeptide, both its presence and
ass could be determined. The single-ion chromato-
ram (SIC) for the ion current from the 279 m/z frag-
ment ion clearly indicated the elution of a phos-
phopeptide at a retention time at about 16 min where
a phosphopeptide eluted (Fig. 3A). Figure 3B shows
the negative-ion mass spectrum for the chromato-
graphic peak in Fig. 3A at 16 min acquired under
conditions that only partially dephosphorylated the
phosphopeptide. This spectrum, compared with the
mass spectrum acquired at the same elution time
under in-source collision-induced dissociation (CID)
conditions, identified a phosphopeptide mass of
[M–H]12 5 1367. When this mass was corrected for the
ass of phosphate, it could be reconciled with the
equence of fragment GSPPSLASSSASQL from NS5A,
orresponding to amino acids 2193–2212 on the HCV
b polyprotein.
he major phosphopeptide represents an in vivo site
of phosphorylation
The procedure used for the identification of the
major phosphopeptide detected in purified NS5A de-
rived from insect cells did not indicate the precise
FIG. 2. Expression and in vitro phosphorylation of recombinant HCV
1b NS5A. (A) Analysis of 1 mg of Sf9 cell-purified native NS5A (NS5AN)
from HCV 1b genotype by SDS–PAGE followed by silver staining. (B)
Autoradiography of 32P-labeled native NS5A 1b resolved by SDS–PAGE
s described under Materials and Methods. (C) In vitro phosphorylation
f NS5A was performed in the absence (lane 1) or presence (lane 2) of
xogenous CKII as above, except that NS5A was first heat-inactivated
t 56°C for 15 min (NS5AHI). Molecular masses are indicated in kDa.
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504 KATZE ET AL.phosphorylated residue. Furthermore, it did not reveal
whether the detected phosphopeptide represented a
site of in vivo phosphorylation if NS5A was expressed
in mammalian cells. To address these questions, we
performed comparative 2-D phosphopeptide mapping
experiments with NS5A phosphorylated in vivo in
mammalian cells and with NS5A phosphorylated in
vitro by insect or by a partially purified yeast NS5A
kinase or kinases. To generate in vivo labeled NS5A,
COS-1 cells were transfected with an NS5A 1b expres-
sion construct and metabolically labeled with 32P-or-
hophosphate. The NS5A protein was immunoprecipi-
ated with antibody specific to NS5A, resolved by
DS–PAGE, and electrotransferred to a nitrocellulose
embrane. For phosphopeptide mapping, NS5A was
igested sequentially with trypsin and chymotrypsin
nd eluted from the membrane, and the resulting pep-
ides were separated on cellulose TLC plates, where
he phosphopeptides were detected by autoradiogra-
hy. This pattern showed several comigrating phos-
hopeptides, including the two designated by arrows
compare Figs. 4A and 4B). As revealed below, these
wo phosphopeptides result from phosphorylation of
er2194. It should be mentioned that the phosphopep-
FIG. 3. Phosphopeptide mapping of the tryptic peptides with mLC-ESI
S5A from Sf9 cells revealed a major phosphopeptide ion at 16 min. (
M–H]12.ide indicated by the right arrow is highly reproducible,
hereas the weaker signal indicated by the left arrows often more difficult to resolve in maps of in vitro
abeled NS5A but not in vivo labeled NS5A. Because
very 2-D phosphopeptide map runs slightly differ-
ntly, we wanted to be confident that the in vivo and in
itro derived phosphopeptides are identical. The pep-
ide spots believed to represent the same phos-
hopeptide were therefore eluted from the cellulose
atrix as before and pooled together for a second 2-D
hosphopeptide map analysis. Indeed, phosphopep-
ide mapping of an equal-counts mixture of the phos-
hopeptides from the in vivo and in vitro labeled NS5A
demonstrated these phosphopeptides comigrated
(data not shown).
Importantly, the two designated phosphopeptides
were also present in the pattern obtained from in vivo
phosphorylation of HCV genotype 1a NS5A (Fig. 4C),
indicating that the phosphopeptides contained con-
served phosphorylation sites. Certainly there were sev-
eral additional phosphopeptides visible in the 2-D map of
NS5A 1b, suggesting that NS5A is phosphorylated on
multiple sites. However, these additional phosphopep-
tides were not detected in the 2-D map of NS5A 1a (Fig.
4C), suggesting that phosphorylation at these multiple
S. (A) SIC for 279 m/z (i.e., PO3
2) of trypsin- and chymotrypsin-digested
ative-ion mass spectrum of this chromatographic peak is shown with
-MS/Msites is probably not conserved between the genotypes
1a and 1b. Furthermore, despite repeated attempts, we
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505MAJOR HCV NS5A PHOSPHORYLATION SITEwere unable to identify these additional 1b phosphopep-
tides by MS (data not shown).
Identification of Ser2194 as a major phosphorylation
site in NS5A
Neither the mammalian expression system nor the
insect kinase copurified with NS5A yielded sufficient
amounts of the phosphopeptides for MS sequencing. To
generate sufficient amounts of the phosphopeptide for
MS determination of the phosphorylated residue or res-
idues, we used the above partially purified yeast kinase
that phosphorylated NS5A in vitro at the same sites that
were also observed by in vivo phosphorylation and by
the copurified insect kinase.
We first examined whether Ser, Thr, or Tyr residues
were phosphorylated on NS5A. Phosphorylation of
baculovirus-expressed NS5A protein in vitro was
greatly enhanced by the partially purified yeast kinase
(data not shown). The NS5A protein was immunopre-
cipitated, resolved by SDS–PAGE, and electroblotted
onto PVDF membranes. The bands corresponding to
phosphorylated NS5A were detected by autoradiogra-
phy, excised from the membranes, and subjected to
phosphoamino acid analysis as described under Ma-
terials and Methods. Autoradiograms of the TLC plates
32
FIG. 4. Two-dimensional migration patterns of in vitro and in v
polyacrylamide gel, the NS5A band from the gel was cut out, and the
peptides of NS5A were separated by 2-D electrophoresis on cellulose
exposed to film for autoradiography. The resulting phosphopeptide ma
B) are shown. The resulting phosphopeptide map of NS5A from HCVfor NS5A indicated the presence of P-labeled Ser, as
etected by comigration with the nonradiolabeled, nin-ydrin-stained phospho-Ser standard (Fig. 5, top and
ottom), indicating that Ser is the predominant phos-
horylated amino acid.
Tryptic digests of the radiolabeled NS5A protein were
hen separated by reverse phase (RP)-HPLC. Fractions of
min were manually collected, and the radioactivity they
ontained was determined by Cerenkov counting and
lotted against the elution time (Fig. 6A). In agreement
sphorylated NS5A peptides. After electrophoresis on a 9% SDS–
lice was subjected to trypsin digestion. The released phosphotryptic
ates as described under Materials and Methods, and the plates were
S5A from HCV 1b genotype labeled in vivo (panel A) or in vitro (panel
otype labeled in vivo is shown in panel C. See text for details.
FIG. 5. Phosphoamino acid analysis of in vitro labeled NS5A 1b. Sf9
cell-purified NS5A 1b was phosphorylated in vitro, size-fractionated by
SDS–PAGE, and transferred to PVDF. NS5A bands were excised and
subjected to phosphoamino acid hydrolysis as described under Mate-
rials and Methods. (A) Phosphoamino acid standards visualized with
ninhydrin showing the positions of phospho-Ser, phospho-Thr, and
phospho-Tyr. (B) In vitro labeled NS5A 1b contains predominately phos-ivo pho
gel s
TLC plpho-Ser. Bars denote the positions of migration of the ninhydrin stan-
dards.
m
l
9
G
p
s
g
H
m
i
a
m
m
(
F
rm of t
n s the p
506 KATZE ET AL.with the RP-HPLC peptide maps from the purified, insect-
cell derived NS5A (Fig. 3A), this profile showed a single
major phosphopeptide peak (retention time 8–12 min),
representing about 80% of the total counts per minute
eluting from the HPLC column. The radioactive fractions
were pooled and subjected to negative-ion and positive-
ion capillary mLC-ESI-MS/MS for mass analysis, se-
quencing, and determination of the phosphorylated res-
idue or residues in the phosphopeptide or phosphopep-
tides present in the collected fractions. Negative-ion
capillary HPLC-ESI-MS scans continuously alternating
between full-scan mode and single-ion monitoring iden-
tified a single phosphopeptide with m/z 5 937 (Fig. 6B).
This mass was compatible with the NS5A sequence
GSPPSLASSSASQLSAPSLK, which contains the se-
quence peptide GSPPSLASSSASQL that was initially
identified as the peptide containing the major phosphor-
ylation site in insect cell-derived NS5A by trypsin/chymo-
trypsin digestion.
Positive-ion mLC-ESI-MS/MS of fraction 8 with auto-
ated data-dependent CID identified the nonphosphory-
FIG. 6. Identification of Ser2194 as a major NS5A phosphorylation site. (
HPLC column by elution with increasing concentrations of CH3CN. One
ractions are indicated by l. (B) Full scan mass spectrum of fraction
and was identified as GSPPSLASSSASQLSAPSLK. A phosphorylated fo
onphosphorylated and (D) phosphorylated peptide, where M* denoteated peptide GSPPSLASSSASQLSAPSLK with m/z 5
37 (Fig. 6C), which contains the sequence peptide
c
fSPPSLASSSASQL that was initially identified as the
eptide containing the major phosphorylation site in in-
ect cell-derived NS5A by trypsin and chymotrypsin di-
estion. No CID from phosphopeptides was identified.
owever, the [M 1 2H]21 ion of the putative phosphopep-
tide form of GSPPSLASSSASQLSAPSLK was found to be
present at 1/64th the ion intensity of the nonphosphory-
lated 21 ion, suggesting that the phosphopeptide rep-
resented a minor species (Fig. 6B). Fractions 9, 10, and
11 were pooled and used for a second positive-ion mLC-
ESI-MS/MS experiment in which Q1 continuously se-
lected for fragmentation of only the [M 1 2H]21 ion with
/z 5 977 resulting in the tandem mass spectrum shown
n Fig. 6D. The MS/MS spectra of the nonphosphorylated
nd phosphorylated peptide were compared to deter-
ine the location of the phosphorylated residue. A frag-
ent ion corresponding to PPSLASSSASQLSAPSLK
which lacks Ser2194) was detectable in the spectrum of
the phosphorylated peptide. From these data and sub-
sequent peptide sequence analysis by Edman sequence
chemistry where the majority of 32P eluted in cycle 2, we
tides from in vitro phosphorylated NS5A were fractionated on a 200-mm
32P-labeled peak was observed, indicating one major phosphopeptide.
major peptide in the fraction produced an ion with [M 1 2H]21 5 937
his peptide was identified at [M 1 2H]21 5 977. MS/MS analysis of (C)
hosphorylated form.A) Pep
major
8. Theoncluded that the peptide was phosphorylated on the
irst Ser residue, at position 2194.
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507MAJOR HCV NS5A PHOSPHORYLATION SITEPhosphopeptide mapping of mutant Ser2194 NS5A and
ts interaction with PKR
As additional confirmation that NS5A was phosphory-
ated on Ser2194, we used site-directed mutagenesis to
introduce an Ser-to-Ala mutation at this site (NS5A-
S2194A). Phosphopeptide mapping of in vivo labeled
NS5A-S2194A demonstrated the loss of two phos-
phopeptides (Figs. 7A and 7B), demonstrating that Ser2194
is important for NS5A phosphorylation. The two addi-
tional prominent phosphopeptides found in the tryptic
map of wild-type NS5A 1b, but not NS5A 1a (Fig. 4), were
not abolished in the map of NS5A-S2194A. At any rate,
the fact that NS5A-S2194A was still phosphorylated at
other nonsubstituted residues also suggests that the
conformation of this mutant protein is likely not signifi-
cantly modified by the substitution and is still recogniz-
able by the protein kinase.
Because phosphorylation of NS5A at Ser2194 may alter
the conformation or surface of the protein to promote
and/or disrupt protein–protein interaction, we examined
the potential contribution of NS5A phosphorylation to its
biological functions. One immediate idea relates to the
ability of NS5A to inhibit the PKR protein kinase via a
direct protein–protein interaction mechanism (Gale et al.,
1997, 1998). We thus examined the PKR-interactive prop-
erties of NS5A 1b and mutant S2194A by using recom-
binant NS5A proteins fused to glutathione S-transferase
(GST) as an affinity matrix to precipitate lysates from
HeLa cells. The precipitated proteins were analyzed by
Western blotting by using an anti-PKR antibody. As
shown in Fig. 7C, GST-NS5A 1b or GST-S2194A, but not
GST control, bound PKR (top panel). Western blot analy-
sis using an anti-NS5A antibody indicated that all GST-
NS5A 1b and -S2194A fusions were expressed to com-
parable levels (bottom panel). These results suggest that
phosphorylation of Ser2194 is probably not required for
KR inhibitory function.
DISCUSSION
The phosphorylation of NS5A (or NS5) is conserved
mong divergent HCV isolates (Reed et al., 1997) and
mong other members of the Flaviviridae (Reed et al.,
998), suggesting it may play an important role in the
lavivirus life cycle. To begin to determine the role of
hosphorylation in modulating NS5A, we attempted to
dentify the phosphorylation sites of NS5A by using a
ell-established approach that combined 2-D phos-
hopeptide mapping and ESI-MS (Fig. 1). To this end, we
ere able to determine a major site of NS5A phosphor-
lation in vitro by using recombinantly expressed and
urified NS5A and the recovered tryptic phosphopep-
ides from 2-D phosphopeptide maps. By comparison of
hese data with the tryptic phosphopeptide maps of in
ivo phosphorylated NS5A, isolated from NS5A-express-
ng COS-1 cells after 32P metabolic labeling, we were
f
pable to determine the major phosphopeptide as NS5A
residues GSPPSLASSSASQLSAPSLK and the site of
phosphorylation as Ser2194. Phosphorylation at Ser2194was
FIG. 7. Effects of Ser2194-to-Ala mutation (S2194A) on the patterns of in
ivo HCV 1b NS5A phosphorylation. Two-dimensional phosphopeptide
ap analysis of NS5A was performed as described in the legend to Fig.
. Wild-type NS5A from HCV 1b genotype was phosphorylated at Ser2194
(indicated by arrows) in vivo (panel A). In contrast, NS5A-S2194A did not
contain these phosphopeptides (panel B). (C) Phosphorylation of Ser2194
does not influence NS5A binding to PKR. GST, GST-NS5A 1b, or GST-
S2194A proteins were expressed and purified from Escherichia coli
cells as described under Materials and Methods. The purified fusion
proteins (1 mg) immobilized on glutathione-agarose beads were incu-
bated with protein lysates (1 mg) prepared from HeLa cells in PBS
buffer containing 0.5% Triton X-100 for 4 h at 4°C. The samples were
washed twice with PBS, and the bound proteins on the beads were
analyzed by SDS–PAGE (12% gel) and Western blotting with a mono-
clonal antibody to human PKR (top panel) or NS5A (bottom panel).urther verified by using site-directed mutagenesis and
hosphopeptide map analysis (Figs. 7A and 7B).
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508 KATZE ET AL.Although the NS5A-S2194 mutant retained the ability to
interact with PKR (Fig. 7C), it remains possible that NS5A
phosphorylation still plays a role in the ability of NS5A to
confer resistance to interferon, perhaps the best-charac-
terized function of the protein. In addition, it has been
reported that NS5A may be cleaved by a caspase-like
protease or proteases in mammalian cells in an apop-
totic-dependent manner, resulting in a cleaved form that
is localized in the nucleus, and displays transcriptional
activity on coproduction with the a-catalytic subunit of
protein kinase A (PKA) (Satoh et al., 2000). We are there-
fore currently conducting a detailed analysis of the po-
tential role of Ser2194 phosphorylation on NS5A cleavage
nd biological function and effects on the association of
S5A with other proteins, including other HCV nonstruc-
ural proteins. Previous studies using deletion mapping
nd site-directed mutagenesis showed that Ser2197,
Ser2201, and Ser2204 may be required for hyperphosphory-
ation of NS5A (Tanji et al., 1995). However, the differen-
ial phosphorylation of NS5A in these studies was as-
essed by SDS–PAGE gel-shift analysis, which is not a
eliable indicator of the sites or levels of protein phos-
horylation. We also are currently attempting to directly
dentify the NS5A hyperphosphorylation sites by MS and
ubsequently examine the role of these additional phos-
horylation events in the regulation of NS5A function.
The major NS5A phosphopeptide sequence
SPPSLASSSASQLSAPSLK is highly specific to HCV
S5A proteins. This peptide does not appear to contain
ny known consensus phosphorylation sequences for
ecognition by CKII or PKA, which was previously impli-
ated in NS5A phosphorylation (Ide et al., 1997; Kim et
l., 1999). However, this does not exclude the possibility
hat docking sites for CKII and PKA may exist elsewhere
n the NS5A protein. The Ser2194 phosphorylation site
ay contain a consensus phosphorylation sequence
-[SP]-) for proline-directed protein kinases such as the
DC/CDK family of cyclin-dependent and MAPKs, con-
istent with previous results obtained from the inhibitor
rofile of the NS5A-associated kinases (Reed et al., 1997,
998; Reed and Rice, 1999). In regard to the latter family
f protein kinases, it is worth noting that NS5A was
ecently implicated in modulating MAPK signaling (Tan et
l., 1999). It might be interesting to determine whether
rb2–NS5A interactions are influenced by NS5A phos-
horylation and whether Pro2195 is necessary for Ser2194
phosphorylation.
When a search was performed against the sequence
GSPPSLASSSASQLSAPSLK in the PIR database (Barker
et al., 2000), the last Ser in the peptide sequence ap-
pears to be a putative PKC phosphorylation consensus
sequence site ([ST]-X-[RK]). However, the Ser2194 site was
identified from the tryptic/chymotryptic phosphopeptide
that did not contain the PKC phosphorylation consensus
motif. When the sequence GSPPSL was searched
against the OWL database (Bleasby et al., 1994), it
p
Tshared complete conservation with a number of proteins
that are unrelated to HCV. Of particular interest are mem-
bers of the cellular transcription factor ITF-2 (data not
shown), given the recent reports that NS5A has tran-
scriptional activity (Tanimoto et al., 1997; Kato et al., 1997)
and associates with a novel cellular transcription factor
(Ghosh et al., 2000).
The likelihood that phosphorylation at Ser2194 has a
iologically important role is suggested by our observa-
ion that the amino acid sequence surrounding this res-
due is highly conserved across HCV genotypes (Fig. 8A).
his is in contrast to the recently identified Ser2321 site in
CV genotype 1a NS5A (Reed and Rice, 1999), which is
ot as broadly conserved. The Ser 2321 site was phos-
horylated by a protein kinase present in baby hamster
idney cells (Reed and Rice, 1999). Neither our 1a nor the
b NS5A proteins used in our current study contained a
erine at position 2321. Our data indicate that NS5A from
oth genotypes 1a and 1b is probably phosphorylated on
er2194. The sequence surrounding Ser2194 is unusually
ighly conserved compared with the remainder of NS5A
FIG. 8. Alignment of NS5A phosphopeptide sequences from repre-
sentative HCV genotypes. (A) Potential kinase binding region around
Ser2194 is highly conserved. Amino acid sequence alignment of NS5A
from various HCV strains revealed highly conserved region around
Ser2194. Uppercase letters denote conservation of at least 90% across;
owercase letters denote conservation of 50–90%. (B) Ser2194 region is
significantly more conserved than the remainder of the NS5A protein or
the NS5A coding sequence, as revealed by simultaneous protein se-
quence alignment using the MATCH-BOX program (Depiereux and
Feytmans, 1992). E1 is used to genotype HCV strains. The mutations
within the ISDR have been correlated to HCV resistance to IFN therapy
(Enomoto et al., 1995 and 1996). Asterisk denotes P7 nonstructural
protein.rotein or the entire NS5A coding sequence (Fig. 8B).
he conservation of the Ser2194-containing region may
u
t
p
p
o
b
R
e
t
(
c
t
m
S
b
p
U
P
A
p
t
P
d
t
p
G
m
m
C
s
v
p
E
c
t
o
t
S
w
d
1
a
c
509MAJOR HCV NS5A PHOSPHORYLATION SITEindicate a novel consensus recognition motif for the
NS5A protein kinase or kinases. This also suggests that
the NS5A kinase is very likely to be evolutionarily con-
served. Indeed, as discussed earlier, we found by phos-
phopeptide mapping that yeast, insect, and mammalian
cells contain a protein kinase or kinases that are capable
of phosphorylating NS5A on Ser2194. Even though COS-1
cells were used as a source of our mammalian protein
kinase, the observed conservation strongly suggests
that protein kinase in liver cells (the natural site of HCV
replication) also phosphorylates NS5A on Ser2194, al-
though this must be experimentally demonstrated.
Clearly it is critical to identify the cellular protein ki-
nase or kinases responsible for phosphorylation of
NS5A. Based on several reports, including the current
paper, it is likely to form a stable complex with NS5A in
that it can be coprecipitated with NS5A from cellular
extracts (Ide et al., 1997; Reed and Rice, 1999). Rather
unexpectedly, our highly purified NS5A preparation from
baculovirus-infected cells possessed high levels of in-
trinsic kinase activity (Figs. 2A and 2B). The extremely
high purity of the NS5A led us to carefully examine the
possible ability of NS5A to autophosphorylate itself. Al-
though this cannot be formally ruled out, the complete
absence of protein kinase catalytic motifs in the non-
structural protein strongly argue against NS5A possess-
ing inherent kinase activity. On the other hand, in vitro
experiments have suggested that the NS5A protein ki-
nase may be CKII or the cAMP-dependent PKA a-sub-
nit, but the in vivo significance of these findings has yet
o be shown (Ide et al., 1997; Kim et al., 1999). We have
artially purified a yeast kinase or kinases that appear to
hosphorylate NS5A at Ser2194. The yeast system should
ffer an added advantage of identifying the NS5A kinase
y tandem MS and sequence database analysis.
MATERIALS AND METHODS
eagents and antibodies
Cell culture medium for Sf9 cells (Invitrogen, San Di-
go, CA) or HeLa cells (American Type Culture Collec-
ion, Rockville, MD) was purchased from GIBCO BRL
Grand Island, NY). All materials used for protein purifi-
ation were obtained from Amersham Pharmacia Bio-
ech (Arlington Heights, IL). [g-32P]ATP and 32P-or-
thophosphate for in vitro and in vivo labeling experi-
ents, respectively, were purchased from NEN Life
cience Products Inc. (Boston, MA). Monoclonal anti-
ody to NS5A and fully active, recombinant CKII was
urchased from ID Labs (London, Ontario, Canada) and
pstate Biotechnology (Lake Placid, NY), respectively.
KR-specific monoclonal antibody was a gift from Dr.
. G. Hovanessian (Laurent et al., 1985). GST-specific
olyclonal antibody was purchased from Santa Cruz Bio-
echnology (Santa Cruz, CA).
(
slasmid construction and site-directed mutagenesis
All molecular cloning techniques were performed as
escribed previously (Sambrook et al., 1989). Construc-
ion of pCDNA3-NS5A 1b and pGEX2T-NS5A 1b was
reviously described by Neddermann et al. (1999) and
ale et al. (1998), respectively. We used site-directed
utagenesis (Chameleon double-stranded site-directed
utagenesis kit; Stratagene) to substitute Ala for Ser2194
of NS5A 1b in the pCDNA3–NS5A 1b and pGEXT2T–
NS5A 1b constructs using the mutagenic primers CTA-
AGCTGGCCAGGGGGGCCCCCCCCTCCTTG (sense) and
AAGGAGGGGGGGGCCCCCCTGGCCAGCTTAC (anti-
ense). The nucleotide sequence of each construct was
erified by dideoxy nucleotide sequence analysis (Ap-
lied Biosystems, Foster City, CA).
xpression and purification of recombinant NS5A
Isolation of recombinant baculovirus DNA (Bacmid)
ontaining the NS5A coding region under the transcrip-
ional control of the polyhedrin promoter and transfection
f Sf9 cells (Invitrogen) were performed as described by
he manufacturer (BAC-TO-BAC Baculovirus Expression
ystem; GIBCO BRL). For protein expression, Sf9 cells
ere infected with the recombinant baculovirus at a
ensity of 2 3 106 cells/ml at a ratio of about five virus
particles per cell. After 4 days of infection at 27°C, cells
were collected by centrifugation, and cell extract was
prepared in lysis buffer containing 25 mM HEPES (pH
7.5), 20% glycerol, 1% Triton X-100, 300 mM NaCl, 1 mM
EDTA, 2 mM DTT, and protease inhibitors (Complete;
Boehringer Mannheim, Indianapolis, IN). Cell extract was
clarified by centrifugation at 100,000 3 g, filtered through
DEAE-Sepharose, and loaded onto a Resource Q col-
umn. Active fractions were pooled and loaded onto a
gel-filtration Superdex-200 column, previously equili-
brated with lysis buffer containing 500 mM NaCl and
0.2% Triton X-100. NS5A-containing fractions were dia-
lyzed against 50 mM NaCl and loaded onto a Blue-
Sepharose column. After stepwise elution with 500 mM
NaCl, NS5A-containing fractions were concentrated on a
Mono Q column. Expression and purification of GST-
NS5A fusion proteins were performed as previously de-
scribed (Gale et al., 1997).
Yeast extract fractionation
Cell extracts from yeast Saccharomyces cerevisiae
strain K1322 were prepared by using the glass-bead
method as described previously (Gale et al., 1998). Total
extracts were subject to 100,000 3 g centrifugation for
h at 4°C. Proteins were precipitated from the S-100 by
mmonium sulfate fractionation. Ammonium sulfate pre-
ipitates were resuspended in buffer A [25 mM Tris–HClpH 8.0), 1 mM EDTA, 10% glycerol], and ammonium
ulfate was removed by dialysis against the same buffer.
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510 KATZE ET AL.Fractions were assayed for NS5A kinase activity through
the use of GST-NS5A substrate as described later. Frac-
tions with kinase activity were passed over a Q-Sepha-
rose column (Amersham Pharmacia Biotech). Bound pro-
teins were eluted with a 50-ml linear gradient of NaCl
(0–500 mM) in buffer A. Fractions (1 ml) were collected
and assayed for NS5A kinase activity.
In vitro kinase assays for NS5A 1b phosphorylation
by an associated insect kinase
Sf9 cell-purified NS5A 1b was labeled according to the
following protocol: the purified protein fraction contain-
ing the most kinase activity was dissolved in 23 kinase
buffer [100 mM Tris–HCl (pH 7.2), 20 mM MgCl2, 2 mM
TT]. A mixture of [g-32P]ATP and ATP with a predeter-
ined specific activity (between 1000 and 100,000 dpm/
mol of ATP) was added so that the reaction mixture
ontained at least 100-fold molar excess of ATP over the
rotein concentration. The reaction was then incubated
t 30oC for 1 h and stopped by flash freezing in an
thanol–dry ice bath. An equal volume of 23 SDS protein
oading buffer [125 mM Tris–HCl (pH 6.8), 20% glycerol,
% SDS, 2% b mercaptoethanol, and 0.02% bromphenal
blue] was added, and the samples were boiled for 5 min.
Proteins were resolved by SDS–PAGE (a 9% gel). The
NS5A phosphorylation band was detected by autora-
diography of the gel.
In vitro kinase assays for NS5A phosphorylation by a
partially purified yeast fraction containing kinase
activity
The protocol described above for the insect cell kinase
was used with the following exception: 20 ml of F47
raction (yeast fraction containing most of the kinase
ctivity) was added in four 5-ml aliquots every 15 min to
the Sf9 cell-purified NS5A. This procedure was adopted
specifically for high-level efficient labeling of NS5A be-
cause the yeast NS5A kinase appears to be labile and is
active for only about 15 min.
Transient expression and in vivo labeling
DNA transfection was performed with the SuperFect
(Qiagen, Studio City, CA) as described by the manufac-
turer using 7 mg of the DNA construct pCD5A per 3–6 3
106 COS-1 cells in T-25 flasks. After 24 h of gene expres-
ion, cells were washed with Hanks’ balanced salt solu-
ion (HBSS) (GIBCO BRL) and incubated for an additional
h with phosphate-free medium (GIBCO BRL) supple-
ented with 10% dialyzed calf serum and 1500 mCi/ml of
32P-orthophosphate. Cells were then washed once with
BSS, harvested in TEKTN buffer [20 mM Tris–HCl (pH
.5), 1 mM EDTA, 50 mM KCl, 0.5% TX-100, 50 mM NaCl]
upplemented with 20% glycerol, 100 mM PMSF, 25 mM
aF, 1 mM DTT, 10 mg/ml aprotinin, 1 mM okadaic acid,
nd 1 mM Na3VO4.Immunoprecipitation assay for in vivo labeling of
NS5A
Protein lysates prepared from 5 3 106 cells were
ncubated with 2 ml of anti-NS5A monoclonal antibody for
0 min followed by absorption to 100 ml of protein G–aga-
rose beads (Boehringer Mannheim) for 120 min at 4°C in
1-ml volume of TEKTN buffer supplemented with pro-
tease and phosphatase inhibitors as described above.
Phosphoamino acid analysis
Proteins labeled in vivo or in vitro were electrotrans-
ferred from a 9% SDS–polyacrylamide gel onto the PVDF
membrane, and the radioactive bands on the membrane
were detected by autoradiography. The autoradiogram
was aligned with the PVDF membrane, and the radioac-
tive bands of interest were cut out with a scalpel and
subjected to Cerenkov scintillation counting (no scintil-
lant present; tritium channel energy setting). Bands were
then pre-wet with methanol immersed in water and cut
while still wet into pieces of ;1 mm2 with a clean razor
blade. The pieces were transferred into a Pierce Reac-
tivial, excess water was removed, and 150 ml of constant
oiling 6N HCl (Pierce Chemical Co., Indianapolis, IN)
as added. The sealed vial was placed in a preheated
106–108°C) metal block for 1 h and cooled to room
emperature, and the supernatant was transferred to a
icrocentrifuge tube and vacuum dried. The residue was
dded with 150 ml of water, vacuum dried, resuspended
in an additional 50 ml of water, and vacuum dried again.
The radioactive sample was added with 1 ml of 5 mg/ml
phospho-Tyr, phospho-Ser, and phospho-Thr as migra-
tion markers for the respective phosphoamino acids. The
sample was applied to a 20 3 20-cm thin-layer cellulose
(TLC) plate (Eastman Kodak) and separated by electro-
phoresis in 5% acetic acid, 0.5% pyridine for 60 min at
1000 V and 10°C in the negative-to-positive direction
(Gallis et al., 1999). The plate was dried extensively in a
fume hood, sprayed with 0.1% ninhydrin in 100% ethanol,
and dried under a heat lamp until the phosphoamino
acid markers developed. The plate was exposed to film,
which was then aligned with the plate to determine the
identity of phosphoamino acids present in the protein.
Two-dimensional phosphopeptide mapping
Two-dimensional phosphopeptide mapping was per-
formed essentially as described (Affolter et al., 1994;
Goodlett et al., 2000). Phosphorylated proteins were sep-
arated by SDS–PAGE and electroblotted onto a nitrocel-
lulose membrane. Radioactive bands were detected by
autoradiography of the membrane, cut out, and quanti-
fied by Cerenkov counting. The nitrocellulose bands
were sliced into 0.5 3 1-mm pieces, treated with 1%
PVP-40 in 100 mM acetic acid at 37°C for 1 h to block
protease absorption, and washed thoroughly with deion-
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511MAJOR HCV NS5A PHOSPHORYLATION SITEized water (8–12 times in 1-ml volume). The pieces were
suspended in 200 ml of ammonium bicarbonate (pH 8.3),
and the proteins absorbed to the nitrocellulose were
digested by 1 mg of trypsin for 3 h at 37°C. Digestion was
ontinued at 37°C overnight after the addition of a sec-
nd 1-mg aliquot of trypsin. The next day, 1 mg of chy-
motrypsin was added, and proteolysis was continued for
3 h at 37°C. Supernatants were then removed, and slices
were washed twice with water to extract any remaining
peptides. Phosphopeptide release was monitored at ev-
ery step by Cerenkov counting. Recovered samples were
dried, resuspended in 10 ml of 20% acetonitrile, and
oaded onto cellulose TLC plates (20 3 10 cm). The
hosphopeptides were separated in the first dimension
20 cm) by electrophoresis in 10% acetic acid, 1% pyri-
ine at 1000 V for 60 min in reverse polarity. The plates
ere dried overnight in a fume hood and developed in
he second dimension (10 cm) by ascending chromatog-
aphy in 30% 1-butanol, 30% pyridine, and 6% acetic acid.
he plates were dried extensively and autoradiographed.
mLC and MS
Purified NS5A protein was subjected to trypsin diges-
tion, and the resulting peptide mixture was analyzed by
negative-ion mLC-ESI-MS/MS using a diagnostic ion-
canning procedure that indicated the presence of phos-
hopeptides in the column effluent as well as their mo-
ecular weights. This was achieved by the cyclic appli-
ation of three sequential scanning conditions under
utomated instrument control. First, peptides were sub-
ected to fragmentation immediately after ionization but
efore mass separation on the triple quadrupole mass
pectrometer in a procedure termed in-source CID. In
his procedure, a high declustering potential causes the
elective loss of phosphate from phosphopeptides and
enerates the phosphate specific reporter ions at 263,
79, and 297 m/z. The intensity of the ions as a function
f time is represented in Fig. 3A. Second, under the same
n-source CID conditions, a full-scan spectrum was re-
orded, which indicated the mass of the analytes eluting
rom the column, including the mass of the dephospho-
ylated peptide. Third, a mass spectrum was acquired
nder a reduced declustering voltage where only a frac-
ion of the phosphopeptides was dephosphorylated. Be-
ause these three conditions were cycled fast in com-
arison to the elution time of the phosphopeptide, both
ts presence and mass could be determined.
For separation of radioactive peptides, a 200-mm i.d.
polyimide capillary (Polymicro Technologies, Tucson, AZ)
was slurry packed at 1000 p.s.i. with ODSAQ C18 (YMC,
Wilmington, DE) to 12 cm using a pressure cell (Mass
Evolution, Inc., Houston, TX). Peptides were eluted by
linear gradient of acetonitrile using an HP1100 binary
pump (Hewlett Packard, Palo Alto, CA) where solvent A
consisted of aqueous 0.2% acetic acid (99.999%; Sigma
c
aChemical Co.) with 0.005% heptafluorbutyric acid (Sigma
Chemical Co.). Fractions were collected each minute into
microcentrifuge tubes.
For MS by mLC, a 50-mm 3 10-cm capillary column
was slurry packed with ODSAQ (YMC) using a pressure
cell (Mass Evolution). For ESI, the fritless end of the mLC
column was connected to a VALCO “Tee” type union
(Houston, TX) that was also connected to a restrictive
flow splitter (50 mm 3 2 m) and to the HP1100 pump.
Column effluent was transferred to a New Objective, Inc.
(Cambridge, MA) glass needle with a 30-mm tapered tip
via a VALCO union. Peptides were ionized by ESI by
applying a voltage of 1200 V to the VALCO union. Data-
dependent tandem MS was carried out in positive-ion
mode on a triple quadrupole (TSQ 7000; ThermoQuest,
San Jose, CA). This was done by using an instrument
control language (ICL) procedure that automatically se-
lected the ion for fragmentation based on signal/noise,
or an ion of interest was selected and all other ions were
ignored (Lee et al., 1998). The ICL procedure automati-
cally incremented the collision energy (VCOFF) such that
ID was acquired over a range of VCOFF values rather
than a set value such that prior optimization was not
necessary. A diagnostic ion scan procedure was carried
out in negative-ion mode on the triple quadrupole to
detect and measure molecular ions of phosphopeptides
that used an ICL procedure that continuously alternated
among three different modes of operation. These modes
in the sequence they were conducted were (1) multiple
ion monitoring of 63, 79, and 97 m/z with in-source CID
(Hunt et al., 1986), (2) full scan with in-source CID, and (3)
full scan without in-source CID. The specific ICL proce-
dure was “while astart2/apicid 5 60;prof; scntype 5 1;
t 5 0.6; scn/apicid 5 60;cent; scntype 5 0;st 5 1.0;scn/
picid 5 60;prof; scntype 5 0;st 5 1.0;scn/end,” where/
ndicates a new line in the procedure and was not part of
he ICL language. The ICL procedures are available
t http://depts.washington.edu/;ruedilab/methods/
methods.html.
Peptides were sequenced on a TSQ 7000 triple quad-
upole mass spectrometer (Finnigan, San Jose, CA)
quipped with a custom-built ESI device described pre-
iously (Goodlett et al., 2000). Data acquisition was com-
uter controlled using a program written in ICL that
utomatically provided data-dependent ion selection. Ion
election was dependent on ion intensity such that as an
on reached a given intensity, the mass spectrometer
imultaneously switched from full scan mode to MS/MS
ode. After five MS/MS scans, the ICL procedure re-
urned the mass spectrometer to initial scanning condi-
ions. Very low abundance phosphopeptides were se-
uenced by continuous MS/MS of the 21 ion of interest
hroughout an entire chromatographic analysis. The spe-
ific ICL procedure is available at the URL indicated
bove.
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